Phase 3 Drug Therapy Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital276 enrolled1 locationNCT06214195
Active
Phase 3
OVATURE (OVArian TUmor REsponse) study
Epithelial ovarian, fallopian or primary peritoneal cancer that is resistant or refractory to 2-weekly, 3- or 4-weekly platinum drug therapy
Marshall Edwards Pty Ltd340 enrolled5 locationsACTRN12606000471583